A Study of SYS6020 Injection in Refractory Active Systemic Lupus Erythematosus
Clinical trial NCT06694298 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06694298
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-26
- Primary completion
- 2029-01-29
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.